Skip to main content

Postdoctoral Training Opportunity – Nanomedicines for Cancer Treatment

Professors Chad Mirkin and Jochen Lorch of Northwestern University are seeking highly motivated postdoctoral candidates focused on developing novel therapeutics using the spherical nucleic acid (SNA) platform. Specifically, research efforts will be focused on SNA construct design, formulation, and implementation as genetic medicines to treat multiple forms of cancer.

The Postdoctoral Fellow will have a unique opportunity to be co-mentored by both a chemist/nanoscientist (Mirkin) in the Weinberg College of Arts and Sciences (WCAS, Evanston campus) and a clinician (Lorch) in the Feinberg School of Medicine (Chicago campus). Composed of researchers from chemistry, biology, materials science, engineering, and medicine, the Mirkin group fosters a highly interdisciplinary and collaborative research environment.

Qualifications

  • Highly motivated and professional upcoming or recent PhD or MD/PhD graduate in Chemistry, Biomedical or Chemical Engineering, or a similar field (required).
  • Strong publication record in chemistry, biology, and/or cancer immunology.
  • Expertise in molecular biology analytical techniques and assays, such as Western blots, PCR, ELISA, confocal microscopy, and flow cytometry.
  • Experience in mouse tumor models, including syngeneic and transgenic models, and the generation of vectors and transformed cell lines.
  • Strong communication skills and proven success working in a rigorous, collaborative research environment.

To apply, please send a cover letter (describing your career goals and how you plan to apply your skillset to this position), a CV, and the names of at least three references (including contact information) to Professor Chad A. Mirkin.

Northwestern University is an Equal Opportunity, Affirmative Action Employer of all protected classes, including veterans and individuals with disabilities. Women, underrepresented racial and ethnic minorities, individuals with disabilities, and veterans are encouraged to apply. Hiring is contingent upon eligibility to work in the United States.